Financhill
Buy
52

MIRM Quote, Financials, Valuation and Earnings

Last price:
$41.48
Seasonality move :
3.04%
Day range:
$40.58 - $42.85
52-week range:
$23.14 - $48.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.37x
P/B ratio:
8.59x
Volume:
1.2M
Avg. volume:
453.8K
1-year change:
34.78%
Market cap:
$2B
Revenue:
$186.4M
EPS (TTM):
-$2.07

Earnings Data

Next earnings date for MIRM
Feb 28
2025
Most recent earnings per share
-$0.30
Beat by $0.15
(Nov 12/2024)
Consensus Estimate
-$0.45
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MIRM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $95.4M -- -- -$0.29 --
11/12/2024 Q3 $82M $90.4M -$0.30 -$0.45 $0.15
08/07/2024 Q2 $75.1M $77.9M -$0.52 -$0.46 -$0.06
05/08/2024 Q1 $70.2M $69.2M -$0.54 -$0.30 -$0.24
02/28/2024 Q4 $67.9M $69.6M -$0.71 -$0.22 -$0.48
11/02/2023 Q3 -- -- -$0.57 -$0.81 $0.24
08/03/2023 Q2 -- -- -$1.94 -$0.79 -$1.15
05/04/2023 Q1 -- -- -$0.80 -$0.97 $0.17
03/08/2023 Q4 -- -- -$0.99 -$0.92 -$0.06
11/09/2022 Q3 -- -- -$1.02 -$1.09 $0.07
08/04/2022 Q2 -- -- -$0.84 -$1.06 $0.22
05/05/2022 Q1 -- -- -$1.17 -$1.38 $0.21
03/09/2022 Q4 -- -- $1.88 $1.84 $0.04
11/15/2021 Q3 -- -- -$1.55 -$1.50 -$0.05
08/05/2021 Q2 -- -- -$1.45 -$1.08 -$0.37
05/06/2021 Q1 -- -- -$1.68 -$0.99 -$0.70
03/09/2021 Q4 -- -- -$1.43 -$0.98 -$0.45
11/12/2020 Q3 -- -- -$0.86 -$0.98 $0.12
08/06/2020 Q2 -- -- -$0.93 -$0.87 -$0.06
05/07/2020 Q1 -- -- -$0.86 -$0.84 -$0.02
03/12/2020 Q4 -- -- -$0.79 -$0.85 $0.06
11/06/2019 Q3 -- -- -$0.84 -$0.63 -$0.21
08/28/2019 Q2 -- -- -$0.59 -$0.59 $0.00

Mirum Pharmaceuticals Earnings Questions

  • How Much did Mirum Pharmaceuticals Generate in Revenue Last Quarter?

    Mirum Pharmaceuticals reported $90.4M worth of top line sales in its most recent quarter.

  • Did Mirum Pharmaceuticals Beat Earnings Last Quarter?

    Mirum Pharmaceuticals announced earnings per share of -$0.30 which represents a beat of analyst forecast a -$0.45 per share.

  • Is Mirum Pharmaceuticals Profitable?

    Mirum Pharmaceuticals reported $69.6M that represents $1.46 per share over the last quarter.

  • What is the Analyst Consensus for Mirum Pharmaceuticals EPS Next Year?

    Mirum Pharmaceuticals's earnings are forecast to decrease from -$4.00 per share to -$3.50 per share next year representing a decrease of -63.52%.

  • When is Mirum Pharmaceuticals's Earnings Date?

    Mirum Pharmaceuticals's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock